3 results
8-K
EX-99.1
RLYB
Rallybio Corp
29 Jun 23
Departure of Directors or Certain Officers
7:30am
, and Steve as CEO, we look forward to seeing the Rallybio team continue to execute on its priorities and build a sustainable, world-class rare disease
DEF 14A
RLYB
Rallybio Corp
25 Apr 22
Definitive proxy
5:03pm
objectives as determined by the Compensation Committee, including those related to building a world-class team and a sustainable company, business
8-K
EX-99.1
RLYB
Rallybio Corp
7 Mar 22
MARCH 2022 TAKING A DEVASTATING DISEASE – AND DEVASTATING IT. We’re going there. Corporate Presentation
8:00am
the course of treatment to prevent maternal alloimmunization and a sustainable commercial supply.
PRODUCT CANDIDATE REQUIREMENTS Clear mechanism
- Prev
- 1
- Next